Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design of immunoliposomes directed against human ovarian carcinoma.
Nässander UK, Steerenberg PA, De Jong WH, Van Overveld WO, Te Boekhorst CM, Poels LG, Jap PH, Storm G. Nässander UK, et al. Among authors: de jong wh. Biochim Biophys Acta. 1995 Apr 12;1235(1):126-39. doi: 10.1016/0005-2736(94)00300-e. Biochim Biophys Acta. 1995. PMID: 7718600 Free article.
Resistance to cytostatic drugs at the cellular level.
Vendrik CP, Bergers JJ, De Jong WH, Steerenberg PA. Vendrik CP, et al. Among authors: de jong wh. Cancer Chemother Pharmacol. 1992;29(6):413-29. doi: 10.1007/BF00684841. Cancer Chemother Pharmacol. 1992. PMID: 1568284 Review. No abstract available.
Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
Fichtinger-Schepman AM, Vendrik CP, van Dijk-Knijnenburg WC, de Jong WH, van der Minnen AC, Claessen AM, van der Velde-Visser SD, de Groot G, Wubs KL, Steerenberg PA, et al. Fichtinger-Schepman AM, et al. Among authors: de groot g, de jong wh. Cancer Res. 1989 Jun 1;49(11):2862-7. Cancer Res. 1989. PMID: 2720647
Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.
Steerenberg PA, Storm G, de Groot G, Claessen A, Bergers JJ, Franken MA, van Hoesel QG, Wubs KL, de Jong WH. Steerenberg PA, et al. Among authors: de groot g, de jong wh. Cancer Chemother Pharmacol. 1988;21(4):299-307. doi: 10.1007/BF00264195. Cancer Chemother Pharmacol. 1988. PMID: 3370737
Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adducts.
Vendrik CP, Fichtinger-Schepman AM, van Dijk-Knijnenburg WC, de Jong WH, van der Minnen AC, de Groot G, Berends GF, Steerenberg PA. Vendrik CP, et al. Among authors: de groot g, de jong wh. Cancer Chemother Pharmacol. 1997;39(6):479-85. doi: 10.1007/s002800050602. Cancer Chemother Pharmacol. 1997. PMID: 9118458
Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.
Rutten VP, Klein WR, De Jong WA, Misdorp W, Steerenberg PA, De Jong WH, Den Otter W, Ruitenberg EJ. Rutten VP, et al. Among authors: de jong wh, de jong wa. Cancer Immunol Immunother. 1991;34(3):186-90. doi: 10.1007/BF01742311. Cancer Immunol Immunother. 1991. PMID: 1756535 Free PMC article. Clinical Trial.
167 results